Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab.

MLA

Murakhovskaya, Irina, et al. “Healthcare Resource Utilization of Patients with Warm Autoimmune Hemolytic Anemia Initiating First Line Therapy of Oral Corticosteroids with or without Rituximab.” Annals of Hematology, vol. 103, no. 4, Apr. 2024, pp. 1139–47. EBSCOhost, https://doi.org/10.1007/s00277-023-05613-8.

APA

Murakhovskaya, I., Crivera, C., Leon, A., Alemao, E., Anupindi, V. R., DeKoven, M., Divino, V., Lin, I., Shu, C., & Ebrahim, T. (2024). Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab. Annals of Hematology, 103(4), 1139–1147. https://doi.org/10.1007/s00277-023-05613-8

Chicago

Murakhovskaya, Irina, Concetta Crivera, Ann Leon, Evo Alemao, Vamshi Ruthwik Anupindi, Mitch DeKoven, Victoria Divino, Iris Lin, Cathye Shu, and Tarek Ebrahim. 2024. “Healthcare Resource Utilization of Patients with Warm Autoimmune Hemolytic Anemia Initiating First Line Therapy of Oral Corticosteroids with or without Rituximab.” Annals of Hematology 103 (4): 1139–47. doi:10.1007/s00277-023-05613-8.